During a phase of organizational change, Novadip, a biotechnology company specialized in regenerative medicine, was undergoing a transition within its finance team, with the departure of the financial controller, followed by the CFO. In this context, Altesia was engaged to ensure optimal continuity of financial operations and support the rapid onboarding of the new CFO.
Katya Ryjoukhina, an Altesia consultant, initially stepped in to take over the operational tasks of the outgoing financial controller. From her arrival, her role quickly expanded to cover a more strategic scope, ensuring a smooth transition between outgoing and incoming finance teams.